Speakers
Tajuana Bradley, MSN, APRN-BC
Georgia Cancer Specialists
Gwinnett and Cumming
Affiliated with Northside Hospital Cancer Institute
Atlanta, GA
Blanca Ledezma, MSN, NP - AOCNP
Rasheda Persinger, MSN, AGNP-C, AOCNP
Medical Oncology Lead NP
Sidney Kimmel Cancer Center
Sibley Memorial Hospital Johns Hopkins
Washington, DC
Lauren Ritterhouse, MD, PhD
Associate Director, Center for Integrated Diagnostics
Assistant Professor, Harvard Medical School
Assistant Pathologist, Massachusetts General Hospital
Boston, MA
Lauren Ritterhouse, MD, PhD, specializes in diagnostic molecular genetic pathology with expertise in biomarkers for personalized medicine in cancer. She is a member of the Center for Integrated Diagnostics (CID) at Massachusetts General Hospital.
Dr. Ritterhouse joined the Massachusetts General Hospital Department of Pathology and Center for Integrated Diagnostics as a staff pathologist in 2019. Prior to this, she was the Co-Director of the clinical genomics and molecular diagnostic laboratories at the University of Chicago. She received her MD, PhD from the University of Oklahoma where she studied the pathogenic roles of aberrant cytokine production in autoimmunity. She completed a Molecular Genetic Pathology Fellowship at Harvard Medical School and Anatomic Pathology Residency at Brigham and Women’s Hospital in Boston, MA. She is particularly interested in the translation of emerging molecular biomarkers into the clinical laboratory, including those evaluating response to immunotherapy, solid tumor mutational signature profiling, circulating tumor DNA, as well as hematologic malignancies.
Accreditation and Disclosure Information
TARGET AUDIENCE
This CE activity is intended for oncology nurses and nurse practitioners who provide care for individuals with non-small cell lung cancer (NSCLC).
EDUCATIONAL OBJECTIVES
After completing this CE activity, the participant should be better able to:
-
Collaborate with team members to apply guidelines and best practices for biomarker testing and address barriers to testing
Successful completion of this nursing continuing professional development activity will be awarded 0.5 contact hour and 0.5 contact hour in the area of pharmacology.
Medical Oncology Lead NP
Sidney Kimmel Cancer Center
Sibley Memorial Hospital Johns Hopkins
Washington DC
Speaker’s Bureau: AstraZeneca, Guardant Health
Assistant Professor, Harvard Medical School
Assistant Pathologist, Massachusetts General Hospital
Boston, MA
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, do not have any relevant financial relationship(s) to disclose with ineligible companies unless listed below.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
METHOD OF PARTICIPATION
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
If you have questions regarding your certificate, please contact Nicole Dane via email at ndane@mlieducation.org.
ABOUT THIS ACTIVITY
Medical Learning Institute, Inc. is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters,
Copyright © 2022 Medical Learning Institute, Inc. All Rights Reserved.